Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 2Unknown 1No longer available 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Expanded_access 1

Sponsor

Cancer Type

Genitourinary 4Thoracic 1

Conditions

Prostatic Neoplasms 4Urogenital Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Genital Neoplasms, Male 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 292Prednisone 240enzalutamide 193Leuprolide 185Radiotherapy 179Abiraterone Acetate 169Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 92gallium 68 PSMA-11 81abiraterone 81Specimen Handling 73darolutamide 65Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 52Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Powders × Genitourinary × Clear all
NCT03756311 2026-01-23

Expanded Access to NanoPac

NanOlogy, LLC

No longer available
GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT03899077 2024-02-07

SAVE

Cancer Research Antwerp

Phase 2 Unknown
202 enrolled
Genitourinary

Prostatic Neoplasms

NCT04221828 2022-03-29

Trial of NanoPac Focal Therapy for Prostate Cancer

NanOlogy, LLC

Phase 2 Terminated
1 enrolled 5 charts
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

NCT01481441 2016-07-06

AMC_2011_190

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Terminated
208 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡